CARACAS, VENEZUELA — LataMed AI Corp. (OTC: LMED), a digital health and artificial intelligence technology company focused on telehealth infrastructure and healthcare analytics for emerging markets, announced it expects to formally submit a corporate action request to FINRA today seeking approval of a proposed five-for-one forward stock split, together with proportional increases in the company’s authorized common stock and authorized preferred stock.
The proposed corporate action would apply proportionally to all issued and outstanding shares of common stock and outstanding preferred stock designations, including the Series C Voting Preferred Stock. The company stated that the forward stock split is intended to support broader long-term operational scalability, strategic flexibility, capitalization planning, and future growth initiatives as it continues advancing telehealth infrastructure deployment, healthcare analytics integration, regulatory progression, and commercialization initiatives throughout Latin America and other targeted emerging markets.
The company emphasized that the proposed corporate action does not involve any debt restructuring, recapitalization, or reduction in shareholder ownership percentages. No fractional shares are expected to be issued, and any fractional interests would be rounded up to the nearest whole share pursuant to approved board resolutions.
Management stated that the forward stock split forms part of the company’s broader effort to align its capital structure with its ongoing transition into digital healthcare infrastructure and artificial intelligence-driven telehealth operations. Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., said: “As we continue advancing our operational and commercialization initiatives throughout Latin America, we believe this proposed forward stock split and proportional capital structure expansion may support broader long-term strategic flexibility, operational scalability, and future growth initiatives as we continue building our healthcare technology platform.”
The company recently announced commencement of initial operational activities associated with its telehealth platform infrastructure in Venezuela following receipt of regulatory authorization through the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloria Sanitaria (SACS). This regulatory milestone marks a significant step in the company’s ability to deploy its technology in a key emerging market.
For investors and industry observers, the forward stock split signals LataMed AI’s intent to position its capital structure for future growth, potentially increasing the number of shares outstanding and lowering the per-share price, which could improve liquidity and make the stock more accessible to a broader investor base. However, the company remains a development-stage enterprise that has not generated revenues from its current business operations, and the proposed corporate action is subject to FINRA review and approval, completion of applicable regulatory processing, and final corporate implementation procedures. No assurance can be provided regarding the timing or ultimate effectiveness of the proposed corporate action.
The company’s focus on emerging markets, particularly Latin America, presents both opportunities and risks. While the region offers significant potential for digital health adoption, operations in countries like Venezuela involve legal, regulatory, and economic uncertainties. LataMed AI’s ability to secure and maintain regulatory authorizations, deploy its platform, and generate revenue will be critical to its long-term success.
The proposed forward stock split, if approved, would not change the proportional ownership of existing shareholders but could affect the trading dynamics of the stock. The company’s securities trade on the OTC Markets under the symbol LMED, and limited liquidity and trading volume remain considerations for investors.
For more information, please visit https://latamed.ai or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
